Of note, our study also indicates that leukemic cells in CML exhibit increased expression of procollagen C-endopeptidase enhancer 2 (PCOLCE2). This evidence concerns the gene PCOLCE2 and chronic myelogenous leukemia, BCR-ABL1 positive.